Search hospitals > New Mexico > Farmington
San Juan Oncology Associates
Claim this profileFarmington, New Mexico 87401
Global Leader in Non-Small Cell Lung Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Lymphoma
Conducts research for Leukemia
60 reported clinical trials
3 medical researchers
Summary
San Juan Oncology Associates is a medical facility located in Farmington, New Mexico. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Breast Cancer, Lymphoma, Leukemia and other specialties. San Juan Oncology Associates is involved with conducting 60 clinical trials across 75 conditions. There are 3 research doctors associated with this hospital, such as Sardar Imam, Sardar Z Imam, and Jeffrey Neidhart.Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
metastatic
Stage III
2Lung Cancer
Global LeaderStage IV
metastatic
Stage III
Top PIs
Sardar ImamGSK Investigational Site4 years of reported clinical research
Studies Tumors
Studies Squamous Cell Carcinoma
4 reported clinical trials
5 drugs studied
Sardar Z ImamSan Juan Oncology Associates1 year of reported clinical research
Studies Gastroesophageal Junction Adenocarcinoma
Studies Squamous Cell Carcinoma
3 reported clinical trials
5 drugs studied
Jeffrey NeidhartSan Juan Oncology Associates6 years of reported clinical research
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
1 reported clinical trial
3 drugs studied
Clinical Trials running at San Juan Oncology Associates
Breast Cancer
Non-Small Cell Lung Cancer
Thrombocytopenic Purpura
Lung Cancer
Gastric Cancer
Thrombocytopenia
Pathology
Thrombotic Thrombocytopenic Purpura
Non-Hodgkin's Lymphoma
Myelodysplastic Syndrome
Giredestrant + Everolimus
for Advanced or Metastatic Breast Cancer
This trial is testing if a combination of giredestrant and everolimus works better than other hormone treatments plus everolimus in patients with advanced breast cancer who have already tried other treatments. The drugs work by blocking estrogen receptors and a growth pathway in cancer cells. Everolimus has been shown to improve outcomes in breast cancer patients when combined with hormonal treatments.
Recruiting2 awards Phase 37 criteria
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Disitamab Vedotin + Tucatinib
for Breast Cancer
This clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs or liver instead of your blood. Once they've grown bigger in one spot or spread to other parts of the body, they're harder to treat. This is called advanced or metastatic cancer. Participants in this study must have breast cancer or gastric cancer. Participants must have tumors that have HER2 on them. This allows the cancer to grow more quickly or spread faster. There are few treatment options for patients with advanced or metastatic solid tumors that express HER2. This clinical trial uses an experimental drug called disitamab vedotin (DV). Disitamab vedotin is a type of antibody drug conjugate or ADC. ADCs are designed to stick to cancer cells and kill them. This clinical trial uses a drug called tucatinib, which has been approved to treat cancer in the United States and some other countries. This drug is sold under the brand name TUKYSA®. This study will test how safe and how well DV, with or without tucatinib, is for participants with solid tumors. This study will also test what side effects happen when participants take these drugs. A side effect is anything a drug does to the body besides treating the disease.
Recruiting1 award Phase 1 & 26 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at San Juan Oncology Associates?
San Juan Oncology Associates is a medical facility located in Farmington, New Mexico. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Breast Cancer, Lymphoma, Leukemia and other specialties. San Juan Oncology Associates is involved with conducting 60 clinical trials across 75 conditions. There are 3 research doctors associated with this hospital, such as Sardar Imam, Sardar Z Imam, and Jeffrey Neidhart.